| Literature DB >> 33439973 |
Han Youl Lee1, Maia Jack2, Theresa Poon1, Daniel Noori1, Carolina Venditti1, Samer Hamamji1, Kathy Musa-Veloso1.
Abstract
Effects of isocaloric (sweetness differences but constant calories) preloads and isosweet (caloric differences but constant sweetness) preloads, as well as preloads that were neither isosweet nor isocaloric (sweetness and caloric differences) on subsequent ad libitum meal and total (preload + ad libitum) energy intakes were investigated. Thirty-five crossover studies were eligible for inclusion, representing 116 comparisons (41, isocaloric; 41, isosweet; and 34, neither isosweet nor isocaloric). References of existing reviews and literature from 4 databases were searched. The calculated raw mean differences in ad libitum and total energy intakes were pooled in meta-analyses using a random-effects model and the inverse of the variance as the weighting factor. Energy intakes at an ad libitum meal were significantly lower for low-/no-calorie sweetener (LNCS)-sweetened compared with unsweetened preloads in the isocaloric comparison (-55.5 kcal; 95% CI: -82.9, -28.0 kcal; P < 0.001); however, the difference in energy intake was not significant in additional sensitivity analyses (i.e., removal of comparisons where the matrix was a capsule and when xylitol was the LNCS). For the isosweet comparison, although the pooled energy intake at the ad libitum meal was significantly greater with the LNCS-sweetened preload compared with the caloric sweetener (CS)-sweetened preload (58.5 kcal; 95% CI: 35.4, 81.7 kcal; P < 0.001), the pattern was reversed when total energy intake was considered (-132.4 kcal; 95% CI: -163.2, -101.6 kcal; P < 0.001), explained by only partial compensation from the CS-sweetened preload. The results were similar when assessing ad libitum and total energy intakes when unsweetened compared with CS-sweetened preloads were consumed. Unsweetened or LNCS-sweetened preloads appear to have similar effects on intakes when compared with one another or with CS-sweetened preloads. These findings suggest that LNCS-sweetened foods and beverages are viable alternatives to CS-sweetened foods and beverages to manage short-term energy intake.Entities:
Keywords: acute; ad libitum; caloric sweetener; energy intake; food intake; low-calorie sweetener; noncaloric sweetener; postprandial; preload; short-term
Year: 2021 PMID: 33439973 PMCID: PMC8321874 DOI: 10.1093/advances/nmaa157
Source DB: PubMed Journal: Adv Nutr ISSN: 2161-8313 Impact factor: 8.701
FIGURE 1Literature search process to identify studies in which effects of LNCS, CS, or unsweetened preloads on energy intakes were assessed. CS, caloric sweetener; LNCS, low-/no-calorie sweetener.
Key study attributes and results of the studies in which the effects of CS, LNCS, and UNS preloads on energy intakes were assessed[1]
| Energy intakes—study results[ | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PL | LNCS vs. CS | UNS vs. CS | ||||||||||
| Reference | Sample size and gender[ | Study design (WO) | Vehicle (amount) | Time (min) before ad libitum lunch | CS (wt:vol or wt:wt) | LNCS (wt:vol or wt:wt) | UNS | LNCS vs. UNS | Meal only | PL + meal | Meal only | PL + meal |
| Studies in adults | ||||||||||||
| Akhavan et al. (2011)—experiment 1 ( | 14 M | R, C, DB, X (1 wk) | BEV (300 mL) | 60 bf lunch | — | SUCL (0.04%) | H2O | NSD | — | — | — | — |
| BEV + gelatin (300 mL) | SUCL (0.04%) | H2O | NSD | — | — | — | — | |||||
| Akhavan et al. (2011)—experiment 2 ( | 15 M | R, C, DB, X (1 wk) | BEV (300 mL) | 60 bf lunch | SUC (25%) | SUCL (0.04%) | — | — | NSD | ↓ | — | — |
| GLU + FRU (25%) | SUCL (0.04%) | — | — | NSD | ↓ | — | — | |||||
| Almiron-Roig andDrewnowski (2003) ( | 14 M | C, X (1 wk) | BEV (591 mL) | 135 bf lunch | GLU (4.33%) + FRU (4.77%) | — | H2O | — | — | — | NSD | ↓ |
| 18 F | GLU (4.33%) + FRU (4.77%) | — | H2O | — | — | — | NSD | ↓ | ||||
| Anton et al. (2010) ( | 31 GD NR | C, SB, X (2 d) | Cream cheese (NR) | 20 bf lunch | SUC (NR) | Stevia (NR) | — | — | NSD | NR | — | — |
| ASP (NR) | — | — | NSD | NR | — | — | ||||||
| Björvell and Rössner(1982) ( | 12 M + F | R, C, DB, X (1 wk) | BEV (30 mL) | 20 bf lunch | GLU (25%) | — | H2O | — | — | — | NSD | NR |
| Glycerol (25%) | — | H2O | — | — | — | ↑ | NR | |||||
| Black et al. (1991) ( | 20 M | R, C, SB, X (NR) | BEV (280 mL) | 65 bf lunch | — | ASP (0.6%) | H2O | NSD | — | — | — | — |
| Black et al. (1993) ( | 18 M | R, C, X (1 wk) | BEV (280 mL) | 65 bf lunch | — | ASP (0.12%) | H2O | NSD | — | — | — | — |
| BEV (560 mL) | 65 bf lunch | — | ASP (0.12%) | H2O | NSD | — | — | — | — | |||
| Canty and Chan (1991) ( | NR, M + F | R, C, DB, X (1 to 4 d) | BEV (200 mL) | 60 bf lunch | SUC (10%) | ASP (0.06%) | H2O | NSD | NSD | NR | NSD | NR |
| SUC (10%) | SACC (0.03%) | H2O | NSD | NSD | NR | |||||||
| Cuomo et al. (2011) ( | 10 M + F | R, SB, C, X (≥1 wk) | Carbonated BEV (300 mL) | 0 bf solid meal (assumed breakf) | — | ASP (0.04%) + ACE-K (0.04%) | H2O | NSD | — | — | — | — |
| — | ASP (0.04%) + ACE-K (0.04%) | H2O | NSD | — | — | — | — | |||||
| Noncarbonated BEV (300 mL) | 0 bf liquid meal (assumed breakf) | — | ASP (0.04%) + ACE-K (0.04%) | H2O | NSD | — | — | — | — | |||
| — | ASP (0.04%) + ACE-K (0.04%) | H2O | NSD | — | — | — | — | |||||
| DellaValle et al. (2005) ( | 44 F | C, X (NR) | BEV (360 mL) | w lunch | Cola | Diet cola | H2O | NSD | NSD | ↓ | NSD | ↓ |
| Drewnowski et al. (1994) ( | 24 M + F | C, X (1 wk) | Cream cheese (500 g) | 180 bf lunch | SUC (10%) | ASP (0.1%) | H2O | ↓ | ↑ | NR | ↑ | NR |
| Drewnowski et al. (1994) ( | 24 F | C, X (1 wk) | White cheese (500 g) | 180 bf lunch | SUC (10%) | ASP (0.1%) | H2O | NR | NR | NR | NR | NR |
| Farhat et al. (2019) ( | 30 M + F | R, C, SB, X (4–5 d) | BEV (300 mL) | 30 bf lunch | SUC (20%) | Stevia (0.33%) | H2O | NSD | NSD | NR | NSD | NR |
| Ford et al. (2011) ( | 8 M + F | R, C, SB, X (≥3 d) | BEV (50 mL) | 120 bf lunch | — | SUCL (0.08%) | H2O | NSD | — | — | — | — |
| Gadah et al. (2016) ( | 69 M + F | R, C, X (NR) | BEV (300 mL) | 20 bf lunch | SUC (14%) | SUCL (NR) | — | — | ↑ | NR | — | — |
| Kim (2006) ( | 12 M | R, C, X (≥1 wk) | BEV (400 mL) | 180 bf test meal (assumed lunch) | GLU (18.75%) | SUCL (0.05%) | — | — | NSD | NR | — | — |
| Lavin et al. (2002) ( | 20 M + F | C, X (≥3 d) | BEV (150 g) | 5 bf lunch | SUC (10%) | — | H2O | — | — | — | NSD | NR |
| Maersk et al. (2012) ( | 24 GD NR | R, C, X (≥2 wk) | BEV (500 mL) | 240 bf lunch | SUC (11%) | ASP (NR) | H2O | NSD | NSD | ↓ | NSD | ↓ |
| Monsivais et al. (2007) ( | 37 M + F | C, SB, X (1 wk) | BEV (475 mL) | 140 bf lunch | HFCS (12%) | ASP (NR) | — | — | NSD | ↓ | — | — |
| Ranawana and Henry(2010) ( | 23 M | R, C, X (≥2 d) | BEV (∼325 mL[ | 60 bf lunch | SUC (3%) | ASP + ACE-K (NR) | — | — | ↑ | NSD | — | — |
| 24 F | R, C, X (≥2 d) | BEV (∼325 mL[ | 60 bf lunch | SUC (3%) | ASP + ACE-K (NR) | — | — | NSD | ↓ | — | — | |
| Rodin (1990) ( | 24 M + F | R, C, X (1 wk) | BEV (500 mL) | 38 bf lunch | FRU (10%) | ASP (0.05%) | H2O | NSD | ↑ | NSD | ↑ | NSD |
| GLU (10%) | ASP (0.05%) | NSD | ↓ | NSD | ↓ | |||||||
| Rogers and Blundell(1989) ( | 24 M + F | C, SB, X (1 wk) | Yogurt (235 g) | 65 bf lunch | GLU (21%) | SACC (0.07%) | Plain | ↑ | NR | NSD | NR | NSD |
| Rogers et al. (1988) ( | 12 M + F | R, C, SB, X (NR) | BEV (200 mL) | 65 bf lunch | GLU (25%) | SACC (0.07%) | H2O | NSD | NSD | NR | ↑ | NR |
| ASP (0.08%) | H2O | NSD | NSD | NR | ||||||||
| ACE-K (0.12%) | H2O | NSD | ↑ | — | ||||||||
| Rogers et al. (1990)—experiment 1 ( | 12 M + F | C, DB, X (1 wk) | BEV (200 mL) + CAP | 60 bf lunch | — | ASP (0.12%) in BEV | H2O | NSD | — | — | — | — |
| CAP | 60 bf lunch | — | ASP (0.12%) | CAP | ↓ | — | — | — | — | |||
| Rogers et al. (1990)—experiment 2 ( | 15 M + F | C, DB, X (1 wk) | BEV (200 mL) | 60 bf lunch | — | ASP (0.12%) | H2O | NSD | — | — | — | — |
| CAP | 60 bf lunch | — | ASP (0.12%) | CAP | ↓ | — | — | — | — | |||
| CAP | 60 bf lunch | — | ASP (0.24%) | CAP | ↓ | — | — | — | — | |||
| Rogers et al. (1991) ( | 16 M + F | C, DB, X (1 wk) | CAP | 60 bf lunch | — | ASP (400 mg) | CAP | ↓ | — | — | — | — |
| Rolls et al. (1990) ( | 14 M | R, C, X (≥3 d) | BEV (8 oz) | w lunch | SUC (10%) | ASP (0.05%) | H2O | NSD | NSD | ↓ | NSD | ↓ |
| 30 bf lunch | SUC (10%) | ASP (0.05%) | H2O | NSD | NSD | NSD | NSD | NSD | ||||
| 60 bf lunch | SUC (10%) | ASP (0.05%) | H2O | NSD | NSD | NSD | NSD | NSD | ||||
| BEV (16 oz) | w lunch | SUC (10%) | ASP (0.05%) | H2O | NSD | NSD | ↓ | NSD | ↓ | |||
| 30 bf lunch | SUC (10%) | ASP (0.05%) | H2O | NSD | NSD | NSD | NSD | NSD | ||||
| 60 bf lunch | SUC (10%) | ASP (0.05%) | H2O | NSD | NSD | NSD | NSD | NSD | ||||
| Shafer et al. (1987)—experiment 1 ( | 9 M + F | R, DB, C, X (NR) | BEV (NR) | 60 bf lunch | GLU (25 g) | Xylitol (25g) | H2O | ↓ | NSD | — | NSD | — |
| FRU (25 g) | Xylitol (25g) | H2O | NSD | — | NSD | — | ||||||
| SUC (25 g) | Xylitol (25g) | H2O | NSD | — | NSD | — | ||||||
| Shafer et al. (1987)—experiment 2 ( | 5 F | NR | BEV (NR) | 60 bf lunch | — | ASP (250 mg/100 mL) | H2O | NSD | — | — | — | — |
| — | Xylitol (5g) | H2O | NSD | — | — | — | — | |||||
| — | Xylitol (15g) | H2O | NSD | — | — | — | — | |||||
| — | Xylitol (25g) | H2O | ↓ | — | — | — | — | |||||
| Soenen and Westerterp-Platenga (2007) ( | 40 M + F | R, C, SB, X (4 d) | BEV (800 mL) | 50 bf breakfast | SUC (11.3%) | ASP + ACE-K + cyclamate (NR) | — | — | ↑ | ↓ | — | — |
| HFCS (11.3%) | — | ↑ | ↓ | — | — | |||||||
| Stamataki et al. (2020) ( | 20 M + F | R, C, DB, X (5 d) | BEV (330 mL) | 30 bf lunch | GLU (12.1%) | Stevia (240 ppm) | H2O | ↓ | NSD | ↓ | ↑ | NSD |
| SUC (12.1%) | Stevia (240 ppm) | H2O | ↓ | NSD | ↓ | ↑ | NSD | |||||
| Tey et al. (2017) ( | 30 M | R, C, DB, X (≥5 d) | BEV (500 mL) | 60 bf lunch | SUC (13%) | ASP (0.09%) | — | — | ↑ | NSD | — | — |
| SUC (13%) | MFE (0.13%) | — | — | ↑ | NSD | — | — | |||||
| SUC (13%) | Stevia (0.07%) | — | — | ↑ | NSD | — | — | |||||
| Vozzo et al. (2002)—experiment 1 ( | 10 M + F (Nondiabetics) | R, C, SB, X (≥5 d) | BEV (300 mL) | 180 bf lunch | GLU (25%) | — | H2O | — | — | — | ↑ | NR |
| FRU (25%) | — | H2O | — | — | — | ↑ | NR | |||||
| Vozzo et al. (2002)—experiment 2 ( | 9 M + F (Diabetics) | R, C, SB, X (≥5 d) | BEV (300 mL) | 180 bf lunch | GLU (25%) | — | H2O | — | — | — | NSD | NR |
| FRU (25%) | — | H2O | — | — | — | NSD | NR | |||||
| Woodend and Anderson(2001) ( | 15 M | R, C, X (NR) | BEV (360 mL) | 60 bf lunch | SUC (21%) | SUCL (0.08%) | H2O | NSD | ↑ | NR | ↑ | NR |
| Studies in children | ||||||||||||
| Anderson et al. (1989) ( | 20 M + F | R, C, DB, X (1 d) | BEV (300 mL) | 90 bf lunch | SUC (18%) | ASP (0.1%) | — | — | NSD | NR | — | — |
| Bennett et al. (2018) ( | 28 F | R, C, X (≥1 wk) | BEV (350 mL) | 60 bf lunch | GLU (5.14%) + FRU (4.57%) | — | H2O | — | — | — | NSD | NSD |
| GLU (4.57%) + FRU (6.29%) | — | H2O | — | — | — | ↑ | NSD | |||||
| Hetherington et al. (2000)—experiment 1 ( | 25 M + F | C, DB, X (2 to 4 wk) | Gelatin dessert (100 g) | 120 bf lunch | SUC (17%) | ASP (0.025%) | — | — | NSD | NR | — | — |
| Hetherington et al. (2000)—experiment 2 ( | 31 M + F | C, DB, X (2 to 4 wk) | Gelatin dessert (150 or 225 g) | 120 bf lunch | SUC (17%) | ASP (0.025%) | — | — | ↑ | NR | — | — |
| Poirier et al. (2019) ( | 32 M | R, C, X (NR) | BEV (350 mL) | 60 bf lunch | GLU (5.14%) + FRU (4.57%) | — | H2O | — | — | — | NSD | ↓ |
| GLU (4.57%) + FRU (6.29%) | — | H2O | — | — | — | ↑ | NSD | |||||
1ACE-K, acesulfame potassium; ASP, aspartame; BEV, beverage; bf, before; breakf, breakfast; C, controlled; CAP, capsules; CS, caloric sweetener; DB, double-blind; FRU, fructose; GD, gender distribution; GLU, glucose; HFCS, high-fructose corn syrup; MFE, monk fruit extract; LNCS, low-/no-calorie sweetener; NR, not reported; NSD, no significant differences; PL, preload; R, randomized; SACC, saccharin; SB, single-blind; SUC, sucrose; SUCL, sucralose; UNS, unsweetened; w, with; WO, washout; X, crossover; —, not applicable; ↑, statistically significant increase; ↓, statistically significant decrease.
2The number of participants who completed the study is indicated. When the number of participant “completers” was not indicated, the number of participants randomized is provided.
3For the results on LNCS vs. CS and LNCS vs. UNS comparisons, ↑ indicates that there was a statistically significant increase in energy intake in the LNCS group, relative to the CS or UNS groups, and ↓ indicates that there was a statistically significant decrease in energy intake in the LNCS group, relative to the CS or UNS groups. For the results on UNS vs. CS comparisons, ↑ indicates that there was a statistically significant increase in energy intake in the UNS group, relative to the CS group, and ↓ indicates that there was a statistically significant decrease in energy intake in the UNS group, relative to the CS group.
4The volumes of the CS and LNCS fruit drinks were 349 mL and 325 mL, respectively.
Quality appraisals of studies in which the effects of CS, LNCS, and UNS preloads on energy intakes were assessed[1]
| Reference | Q1 | Q2 | Q3 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10[ | Q11[ | Q12 | Q13 | Q14 | Q15 | Total, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akhavan et al. (2011)—experiment 1 ( | Yes | NR | NR | NR | Yes | NR | NR | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 9 (64) |
| Akhavan et al. (2011)—experiment 2 ( | Yes | NR | NR | NR | Yes | NR | NR | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 9 (64) |
| Almiron-Roig and Drewnowski (2003) ( | No | NR | NR | NR | Yes | Yes | Yes | Yes | NA | Yes | Yes | Yes | Yes | Yes | 9 (69) |
| Anderson et al. (1989) ( | Yes | NR | NR | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR | Yes | Yes | 11 (79) |
| Anton et al. (2010) ( | No | NR | NR | NR | Yes | Yes | Yes | Yes | Yes | NR | Yes | Yes | Yes | Yes | 9 (64) |
| Bennett et al. (2018) ( | Yes | NR | NR | NR | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR | Yes | Yes | 10 (71) |
| Björvell and Rössner (1982) ( | Yes | NR | NR | Yes | Yes | Yes | Yes | Yes | NR | NR | Yes | NR | Yes | Yes | 9 (64) |
| Black et al. (1991) ( | Yes | NR | NR | NR | Yes | NR | NR | Yes | Yes | NR | Yes | Yes | Yes | NR | 7 (50) |
| Black et al. (1993) ( | Yes | NR | NR | NR | Yes | NR | NR | Yes | Yes | NR | Yes | NR | Yes | NR | 6 (43) |
| Canty and Chan (1991) ( | Yes | NR | NR | Yes | Yes | NR | NR | Yes | Yes | NR | Yes | Yes | Yes | NR | 8 (57) |
| Cuomo et al. (2011) ( | Yes | NR | NR | Yes | Yes | NR | NR | Yes | NA | NR | Yes | Yes | Yes | NR | 7 (54) |
| DellaValle et al. (2005) ( | No | NR | NR | NR | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR | Yes | No | 8 (57) |
| Drewnowski et al. (1994) ( | No | NR | NR | NR | Yes | NR | NR | Yes | NA | NR | Yes | NR | Yes | NR | 4 (31) |
| Drewnowski et al. (1994) ( | No | NR | NR | NR | Yes | Yes | Yes | Yes | NA | NR | Yes | NR | Yes | Yes | 7 (54) |
| Farhat et al. (2019) ( | Yes | NR | NR | No | Yes | Yes | Yes | Yes | Yes | NR | Yes | Yes | Yes | Yes | 10 (71) |
| Ford et al. (2011) ( | Yes | NR | NR | No | Yes | Yes | Yes | Yes | NR | Yes | Yes | NR | Yes | Yes | 9 (64) |
| Gadah et al. (2016) ( | Yes | NR | NR | NR | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 11 (79) |
| Hetherington et al. (2000)—exp 1 ( | No | NR | NR | Yes | Yes | NR | NR | Yes | NR | Yes | Yes | NR | Yes | NR | 6 (43) |
| Hetherington et al. (2000)—exp 2 ( | No | NR | NR | NR | Yes | Yes | Yes | Yes | NR | Yes | Yes | NR | Yes | Yes | 8 (57) |
| Kim (2006) ( | Yes | NR | NR | NR | Yes | Yes | Yes | Yes | NR | Yes | Yes | NR | Yes | Yes | 9 (64) |
| Lavin et al. (2002) ( | No | NR | NR | NR | Yes | NR | NR | Yes | NR | NR | Yes | NR | Yes | NR | 4 (29) |
| Maersk et al. (2012) ( | Yes | NR | NR | NR | Yes | Yes | Yes | Yes | NR | Yes | Yes | Yes | Yes | Yes | 10 (71) |
| Monsivais et al. (2007) ( | No | NR | NR | NR | Yes | Yes | Yes | Yes | NR | NR | Yes | Yes | Yes | Yes | 8 (57) |
| Poirier et al. (2019) ( | Yes | NR | NR | NR | Yes | Yes | Yes | Yes | NR | Yes | Yes | NR | Yes | Yes | 9 (64) |
| Ranawana and Henry (2010) ( | Yes | NR | NR | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR | Yes | No | 9 (64) |
| Rodin (1990) ( | Yes | NR | NR | NR | Yes | Yes | Yes | Yes | NR | NR | Yes | NR | Yes | No | 7 (50) |
| Rogers and Blundell (1989) ( | No | NR | NR | Yes | Yes | Yes | Yes | Yes | Yes | NR | Yes | NR | Yes | No | 8 (57) |
| Rogers et al. (1988) ( | No | NR | NR | No | Yes | NR | NR | Yes | Yes | NR | Yes | NR | Yes | NR | 5 (36) |
| Rogers et al. (1990)—exp 1 ( | No | NR | NR | NR | Yes | NR | NR | Yes | Yes | NR | Yes | NR | Yes | NR | 5 (36) |
| Rogers et al. (1990)—exp 2 ( | No | NR | NR | Yes | Yes | NR | NR | Yes | Yes | NR | Yes | NR | Yes | NR | 6 (43) |
| Rogers et al. (1991) ( | No | NR | NR | Yes | Yes | NR | NR | Yes | Yes | NR | Yes | NR | Yes | NR | 6 (43) |
| Rolls et al. (1990) ( | No | NR | NR | NR | Yes | NR | NR | Yes | NR | NR | Yes | NR | Yes | NR | 4 (29) |
| Shafer et al. (1987)—exp 1 ( | Yes | NR | NR | Yes | Yes | NR | NR | Yes | NR | NR | Yes | NR | Yes | NR | 6 (43) |
| Shafer et al. (1987)—exp 2 ( | No | NR | NR | NR | Yes | NR | NR | Yes | NR | NR | Yes | NR | Yes | NR | 4 (29) |
| Soenen and Westerterp-Platenga (2007) ( | Yes | NR | NR | NR | Yes | Yes | Yes | Yes | NA | Yes | Yes | No | Yes | Yes | 9 (69) |
| Stamataki et al. (2020) ( | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | NR | Yes | Yes | Yes | Yes | 13 (93) |
| Tey et al. (2017) ( | Yes | NR | NR | Yes | Yes | Yes | Yes | Yes | NR | Yes | Yes | Yes | Yes | No | 10 (71) |
| Vozzo et al. (2002)—exp 1 ( | Yes | NR | NR | No | Yes | Yes | Yes | Yes | NR | Yes | Yes | NR | Yes | Yes | 9 (64) |
| Vozzo et al. (2002)—exp 2 ( | Yes | NR | NR | No | Yes | Yes | Yes | Yes | NR | Yes | Yes | NR | Yes | Yes | 9 (64) |
| Woodend and Anderson (2001) ( | No | NR | NR | NR | Yes | Yes | Yes | Yes | NA | NR | Yes | NR | Yes | No | 6 (46) |
| Total, | 23 (58) | 1 (3) | 1 (3) | 11 (28) | 40 (100) | 24 (60) | 24 (60) | 40 (100) | 18 (53) | 18 (45) | 40 (100) | 13 (33) | 40 (100) | 20 (50) |
1Questions were as follows: Q1. Was the study described as randomized, a randomized trial, a randomized clinical trial, or an RCT? Q2. Was the method of randomization adequate (i.e., use of randomly generated assignment)? Q3. Was the treatment allocation concealed (so that assignments could not be predicted)? Q4. Were study participants and providers blinded to treatment group assignment? [Omitted because of the nature of the studies and the challenges in blinding (participants can distinguish sweetened from unsweetened; participants likely can also distinguish CS and LNCS)]. Q5. Were the people assessing the outcomes blinded to the participants’ group assignments? Q6. Were the groups similar at baseline on important characteristics that could affect outcomes (e.g., demographics, risk factors, comorbid conditions)? Q7. Was the overall drop-out rate from the study at endpoint 20% or lower of the number allocated to treatment? Q8. Was the differential drop-out rate (between treatment groups) at endpoint 15 percentage points or lower? Q9. Was there high adherence to the intervention protocols for each treatment group? Q10. Were variables on the day of testing controlled (i.e., were participants requested to fast between breakfast and consumption of the preload and/or consume a standardized breakfast)? Q11. Were variables on the day before testing controlled (i.e., was an overnight fast required and were alcohol and/or physical activity restrictions similar in the groups)? Q12. Were outcomes assessed using valid and reliable measures, implemented consistently across all study participants? Q13. Did the authors report that the sample size was sufficiently large to be able to detect a difference in the main outcome between groups with at least 80% power? Q14. Were outcomes reported or subgroups analyzed prespecified (i.e., identified before analyses were conducted)? Q15. Were all randomized participants analyzed in the group to which they were originally assigned (i.e., did they use an intention-to-treat analysis)? CS, caloric sweetener; exp, experiment; LNCS, low-/no-calorie sweetener; NA, not applicable; NR, not reported; Q, question; UNS, unsweetened.
2Q10 was analyzed based on 2 criteria; a “yes” was required for each of the following: 1) participants were requested to fast and 2) participants consumed a standardized breakfast. If the publication did not account for both criteria, the publication received an “NR” for Q10. In the case where the breakfast was the preload or the ad libitum meal, question 10 is NA as the fasting period between the breakfast and preload could not be measured. In this circumstance, overnight fasting was mandatory the day prior to testing and was required in order to score question 11 as a “yes.”
3Q11 was analyzed based on 3 criteria; a “yes” was awarded if: i) participants were requested to fast overnight, AND EITHER 2) physical activity was standardized the night before each testing session OR 3) alcohol consumption was standardized the night before each testing session; otherwise, the publication received an “NR” for Q11.
FIGURE 2Forest plot of the ad libitum energy intakes following consumption of LNCS-sweetened versus unsweetened preloads. Each square symbol is proportional to the weight of the comparison. The diamond represents the pooled effect. Energy intakes at the ALM were significantly lower (by ∼ −55.5 kcal; 95% CI: −82.9, −28.0 kcal; P < 0.001) following the consumption of an LNCS-sweetened versus unsweetened preload. A, adults; ACE-K, acesulfame potassium; ALM, ad libitum meal; ASP, aspartame; BEV, beverage; bf, before; breakf, breakfast; Cap, capsule(s); CARB, carbonated; Cr, cream; CS, caloric sweetener; EI, energy intake; Exp, experiment; F, females; HD, high-dose; LM, liquid meal; LNCS, low-/no-calorie sweetener; M, males; NW, normal-weight; OB, obese; SM, solid meal; UNS, unsweetened.
FIGURE 3Forest plot of the ad libitum meal (A) and total (preload + ALM) (B) energy intakes with consumption of LNCS- versus CS-sweetened preloads. Each square symbol is proportional to the weight of the comparison. The diamond represents the pooled effect. EIs at the ALM were significantly greater (by ∼58.5 kcal; 95% CI: 35.4, 81.7 kcal; P < 0.001) following the consumption of LNCS- versus CS-sweetened preloads (forest plot A). However, total energy intake (from the preload + ALM) was significantly lower (by ∼ −132.4 kcal; 95% CI: −163.2, −101.6 kcal; P < 0.001) (forest plot B). A, adults; ALM, ad libitum meal; ACE-K, acesulfame potassium; ASP, aspartame; BEV, beverage; bf, before; breakf, breakfast; C, children; Cr, cream; CS, caloric sweetener; CYC, cyclamate; EI, energy intake; Exp, experiment; F, females; FRU, fructose; GLU, glucose; Gn, gelatin; HFCS, high-fructose corn syrup; LNCS, low-/no-calorie sweetener; M, males; MFE, monk fruit extract; NR, not reported; NW, normal-weight; OB, obese; SUC, sucrose; TEI, total energy intake.
FIGURE 4Forest plot of the ad libitum meal (A) and total (preload + ALM) (B) energy intakes with consumption of unsweetened versus CS-sweetened preloads. Each square symbol is proportional to the weight of the comparison. The diamond represents the pooled effect. EIs at the ad libitum meal were significantly greater (by ∼73.0 kcal; 95% CI: 49.5, 96.5 kcal; P < 0.001) following the consumption of UNS versus CS-sweetened preloads (forest plot A). However, total energy intake (from the preload + ALM) was significantly lower (by ∼ −94.3 kcal; 95% CI: −132.1, −56.4 kcal; P < 0.001) (forest plot B). A, adults; ALM, ad libitum meal; BEV, beverage; bf, before; C, children; Cl = cola; Cr, cream; CS, caloric sweetener; EI, energy intake; Exp, experiment; F, females; FD, fruit drink; FRU, fructose; HFCS, high-fructose corn syrup; M, males; NW, normal-weight; OB, obese; TEI, total energy intake; UNS/UNSW, unsweetened.
FIGURE 5Graphical representation of the energy intakes with consumption of LNCS- versus CS-sweetened preloads and UNS versus CS-sweetened preloads. The white portion of bar represents the energy intake from the ad libitum meal and the gray portion of the bar represents the energy content of the preload. The numerical energy difference noted is of differences in total energy intake (from the preload + ad libitum meal) between the 2 preload conditions. CS, caloric sweetener; LNCS, low-/no-calorie sweetener; UNS, unsweetened.